Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Loncastuximab in high-risk and heavily pretreated relapse... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers
0
Authors
Viktoriya Zelikson
38 more
Viktoriya Zelikson
•
Ashwath Gurumurthi
36 more
•
Emily Ayers
Published
November 14, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Haematologica
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.3324/haematol.2024.285977
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Haematologica
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.3324/haematol.2024.285977
License
CC-BY-NC
